CNS Pharmaceuticals, Inc. (CNSP) - Latest Market Data

Price & Market Data

Price: $5.42

Daily Change: +$0.37 / 6.83%

Daily Range: $5.07 - $5.48

Market Cap: $7,921,053

Daily Volume: 23,733

Performance Metrics

1 Week: 2.28%

1 Month: 113.0%

3 Months: 57.06%

6 Months: -23.51%

1 Year: -64.50%

YTD: -5.59%

About CNS Pharmaceuticals, Inc. (CNSP)

Understand CNS Pharmaceuticals, Inc. (CNSP)'s current market standing. Current price: 5.42, daily change: +$0.37 / 6.83%. Market cap: 7,921,053. Detailed performance for all periods.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Selected stocks

Toro Corp. (TORO)

Heron Therapeutics, Inc. (HRTX)

Cheetah Net Supply Chain Service Inc. (CTNT)

Playboy, Inc. (PLBY)

Tantech Holdings Ltd. (TANH)